penicillamine has been researched along with Absence Status in 3 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, B | 1 |
Mader, I | 1 |
Damjanovic, K | 1 |
Niesen, WD | 1 |
Stich, O | 1 |
Türk-Börü, U | 1 |
Kocer, A | 1 |
Alp, R | 1 |
Gümüş, M | 2 |
Yoshida, K | 1 |
Maruyama, K | 1 |
Hashimoto, T | 1 |
Shindo, M | 1 |
Shoji, S | 1 |
Yanagisawa, N | 1 |
3 other studies available for penicillamine and Absence Status
Article | Year |
---|---|
Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
Topics: Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance I | 2014 |
Status epilepticus in a case with wilson's disease during D-pencillamine treatment.
Topics: Adult; Cerebral Cortex; Electroencephalography; Hepatolenticular Degeneration; Humans; Magnetic Reso | 2003 |
[A case of Wilson's disease who developed status epilepticus during D-penicillamine therapy].
Topics: Adolescent; Cerebral Cortex; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Status Ep | 1989 |